148 related articles for article (PubMed ID: 31060646)
1. The Immunoscore in the Clinical Practice of Patients with Colon and Rectal Cancers.
Zeitoun G; Sissy CE; Kirilovsky A; Anitei G; Todosi AM; Marliot F; Haicheur N; Lagorce C; Berger A; Zinzindohoué F; Galon J; Scripcariu V; Pagès F
Chirurgia (Bucur); 2019; 114(2):152-161. PubMed ID: 31060646
[TBL] [Abstract][Full Text] [Related]
2. Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.
Becht E; Giraldo NA; Germain C; de Reyniès A; Laurent-Puig P; Zucman-Rossi J; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
Adv Immunol; 2016; 130():95-190. PubMed ID: 26923001
[TBL] [Abstract][Full Text] [Related]
3. Usefulness and robustness of Immunoscore for personalized management of cancer patients.
Marliot F; Pagès F; Galon J
Oncoimmunology; 2020 Oct; 9(1):1832324. PubMed ID: 33194318
[TBL] [Abstract][Full Text] [Related]
4. [Intratumoral immune microenvironment and survival: the immunoscore].
Galon J; Bindea G; Mlecnik B; Angell H; Lagorce C; Todosi AM; Berger A; Pagès F
Med Sci (Paris); 2014 Apr; 30(4):439-44. PubMed ID: 24801041
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive values of the immunoscore in patients with rectal cancer.
Anitei MG; Zeitoun G; Mlecnik B; Marliot F; Haicheur N; Todosi AM; Kirilovsky A; Lagorce C; Bindea G; Ferariu D; Danciu M; Bruneval P; Scripcariu V; Chevallier JM; Zinzindohoué F; Berger A; Galon J; Pagès F
Clin Cancer Res; 2014 Apr; 20(7):1891-9. PubMed ID: 24691640
[TBL] [Abstract][Full Text] [Related]
6. Multiverse of immune microenvironment in metastatic colorectal cancer.
Van den Eynde M; Mlecnik B; Bindea G; Galon J
Oncoimmunology; 2020 Sep; 9(1):1824316. PubMed ID: 33457100
[TBL] [Abstract][Full Text] [Related]
7. The consensus immunoscore: toward a new classification of colorectal cancer.
Lanzi A; Pagès F; Lagorce-Pagès C; Galon J
Oncoimmunology; 2020 Jul; 9(1):1789032. PubMed ID: 32934885
[TBL] [Abstract][Full Text] [Related]
8. [Focus on the Immunoscore and its potential clinical implications].
El Sissy C; Marliot F; Haicheur N; Kirilovsky A; Scripcariu D; Lagorce-Pagès C; Galon J; Pagès F
Ann Pathol; 2017 Feb; 37(1):29-38. PubMed ID: 28161000
[TBL] [Abstract][Full Text] [Related]
9. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
[TBL] [Abstract][Full Text] [Related]
10. The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
Patel M; McSorley ST; Park JH; Roxburgh CSD; Edwards J; Horgan PG; McMillan DC
Br J Cancer; 2018 Mar; 118(5):705-712. PubMed ID: 29337962
[TBL] [Abstract][Full Text] [Related]
11. Regulation of CTL Infiltration Within the Tumor Microenvironment.
Church SE; Galon J
Adv Exp Med Biol; 2017; 1036():33-49. PubMed ID: 29275463
[TBL] [Abstract][Full Text] [Related]
12. The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions.
Pagès F; Taieb J; Laurent-Puig P; Galon J
Oncoimmunology; 2020 Aug; 9(1):1812221. PubMed ID: 32939329
[TBL] [Abstract][Full Text] [Related]
13. The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions.
Lanzi A; Sinicrope FA; Benson AB; Galon J
Oncoimmunology; 2020 Jul; 9(1):1796003. PubMed ID: 32934890
[TBL] [Abstract][Full Text] [Related]
14. The Immunoscore: Colon Cancer and Beyond.
Angell HK; Bruni D; Barrett JC; Herbst R; Galon J
Clin Cancer Res; 2020 Jan; 26(2):332-339. PubMed ID: 31413009
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer.
El Sissy C; Kirilovsky A; Zeitoun G; Marliot F; Haicheur N; Lagorce-Pagès C; Galon J; Pagès F
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33805758
[TBL] [Abstract][Full Text] [Related]
16. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.
Llosa NJ; Cruise M; Tam A; Wicks EC; Hechenbleikner EM; Taube JM; Blosser RL; Fan H; Wang H; Luber BS; Zhang M; Papadopoulos N; Kinzler KW; Vogelstein B; Sears CL; Anders RA; Pardoll DM; Housseau F
Cancer Discov; 2015 Jan; 5(1):43-51. PubMed ID: 25358689
[TBL] [Abstract][Full Text] [Related]
17. Tumor spread or siege immunity: dissemination to distant metastasis or not.
Bindea G; Mlecnik B; Galon J
Oncoimmunology; 2021 Apr; 10(1):1919377. PubMed ID: 33996269
[TBL] [Abstract][Full Text] [Related]
18. [Immunoscore and Its Predictive Value for Colorectal Cancer].
Závadová E; Špaček J; Vočka M; Konopásek B; Fučíková T; Netíková I; Dundr P; Skálová H; Petruželka L
Klin Onkol; 2015; 28 Suppl 4():4S82-5. PubMed ID: 26647895
[TBL] [Abstract][Full Text] [Related]
19. The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.
Bremnes RM; Busund LT; Kilvær TL; Andersen S; Richardsen E; Paulsen EE; Hald S; Khanehkenari MR; Cooper WA; Kao SC; Dønnem T
J Thorac Oncol; 2016 Jun; 11(6):789-800. PubMed ID: 26845192
[TBL] [Abstract][Full Text] [Related]
20. Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer.
Hurtado CG; Wan F; Housseau F; Sears CL
Gastroenterology; 2018 Dec; 155(6):1706-1715. PubMed ID: 30218667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
